These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34637857)

  • 21. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
    Tang TS; Chen X; Liu J; Bezprozvanny I
    J Neurosci; 2007 Jul; 27(30):7899-910. PubMed ID: 17652581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes.
    Chou SY; Weng JY; Lai HL; Liao F; Sun SH; Tu PH; Dickson DW; Chern Y
    J Neurosci; 2008 Mar; 28(13):3277-90. PubMed ID: 18367595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.
    Goodliffe JW; Song H; Rubakovic A; Chang W; Medalla M; Weaver CM; Luebke JI
    PLoS One; 2018; 13(8):e0200626. PubMed ID: 30118496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
    Hwang WJ; Yao WJ
    J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
    Ransome MI; Hannan AJ
    Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.
    Cabanas M; Bassil F; Mons N; Garret M; Cho YH
    PLoS One; 2017; 12(9):e0184580. PubMed ID: 28934250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.
    Pundt LL; Narang N; Kondoh T; Low WC
    Neurosci Res; 1997 Apr; 27(4):305-15. PubMed ID: 9152043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain.
    Dowie MJ; Grimsey NL; Hoffman T; Faull RL; Glass M
    J Chem Neuroanat; 2014 Sep; 59-60():62-71. PubMed ID: 24978314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
    Jiang R; Diaz-Castro B; Looger LL; Khakh BS
    J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease.
    Puginier E; Bharatiya R; Chagraoui A; Manem J; Cho YH; Garret M; De Deurwaerdère P
    Neurochem Int; 2019 Sep; 128():186-195. PubMed ID: 31054882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.
    van Oostrom JC; Dekker M; Willemsen AT; de Jong BM; Roos RA; Leenders KL
    Eur J Neurol; 2009 Feb; 16(2):226-31. PubMed ID: 19138335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.
    Hsiao HY; Chiu FL; Chen CM; Wu YR; Chen HM; Chen YC; Kuo HC; Chern Y
    Hum Mol Genet; 2014 Aug; 23(16):4328-44. PubMed ID: 24698979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease.
    Pineda JR; Canals JM; Bosch M; Adell A; Mengod G; Artigas F; Ernfors P; Alberch J
    J Neurochem; 2005 Jun; 93(5):1057-68. PubMed ID: 15934928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN; Lexow N; Bird E; Winokur A
    Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes.
    Birolini G; Verlengia G; Talpo F; Maniezzi C; Zentilin L; Giacca M; Conforti P; Cordiglieri C; Caccia C; Leoni V; Taroni F; Biella G; Simonato M; Cattaneo E; Valenza M
    Brain; 2021 Nov; 144(10):3175-3190. PubMed ID: 33974044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis.
    Kennedy L; Shelbourne PF; Dewar D
    Brain Res; 2005 Mar; 1039(1-2):14-21. PubMed ID: 15781041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.
    Kim J; Waldvogel HJ; Faull RL; Curtis MA; Nicholson LF
    J Neurochem; 2015 Sep; 134(5):927-42. PubMed ID: 26011179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.
    Pavese N; Politis M; Tai YF; Barker RA; Tabrizi SJ; Mason SL; Brooks DJ; Piccini P
    Neurobiol Dis; 2010 Feb; 37(2):356-61. PubMed ID: 19853661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.